Latest Science Important milestone advances world’s first and only human hookworm vaccine development initiative The Sabin Vaccine Institute (Sabin) today announced that its product development partnership (Sabin PDP) successfully completed a Phase 1 clinical trial in Brazil of Na-GST-1/Alhydrogel®, a vaccine candidate for human... 29 October, 20142 min read